Skip to content

Clinical trials

Phase 1 Pleural Effusion, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Phase: Phase 1 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20061
20091
20132
20141
20162
20192
20202
20211
20221
20233
20245
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting7
Unknown status6
Not yet recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)2
Jemincare2
Abramson Cancer Center at Penn Medicine1
Affiliated Hospital of Jiangnan University1
Assiut University1
Base Therapeutics (Shanghai) Co., Ltd.1
Candel Therapeutics, Inc.1
Centre Hospitalier Universitaire Vaudois1
Clover Biopharmaceuticals AUS Pty1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant30
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms6
Mesothelioma, Malignant6
Breast Neoplasms5
Esophageal Neoplasms4
Neoplasm Metastasis4
Neoplasms4
Anus Neoplasms3
Bile Duct Neoplasms3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.